Accordingly, we sought to confirm the clinical impact of extreme levels of SNHG7 in the tumors of breast cancer patients in the METABRIC45 dataset that includes rich and long-term clinical data from over 2000 patients. This evidence concerns the gene SNHG7 and breast cancer.